Literature DB >> 23792446

Whole chromosome instability resulting from the synergistic effects of pRB and p53 inactivation.

A L Manning1, C Benes1, N J Dyson1.   

Abstract

Whole chromosome instability (CIN) is a common feature of cancer cells and has been linked to increased tumor evolution and metastasis. Several studies have shown that the loss of the pRB tumor suppressor causes mitotic defects and chromosome mis-segregation. pRB is inactivated in many types of cancer and this raises the possibility that the loss of pRB may be a general cause of CIN in tumors. Paradoxically, retinoblastoma tumor cells have a relatively stable karyotype and currently the circumstances in which pRB inactivation causes CIN in human cancers are unclear. Here we utilize a fluorescence in situ hybridization-based approach to score numerical heterogeneity in chromosome copy number as a readout of CIN. Using this technique, we show that high levels of CIN correlate with the combined inactivation of pRB and p53 and that this association is evident in two independent panels of cancer cell lines. Retinoblastoma cell lines characteristically retain a wild-type TP53 gene, providing an opportunity to test the relevance of this functional relationship. We show that retinoblastoma cell lines display mitotic defects similar to those seen when pRB is depleted from non-transformed cells, but that the presence of wild-type p53 suppresses the accumulation of aneuploid cells. A similar synergy between pRB and p53 inactivation was observed in HCT116 cells. These results suggest that the loss of pRB promotes segregation errors, whereas loss of p53 allows tolerance and continued proliferation of the resulting, genomically unstable cancer cells. Hence, it is the cooperative effect of inactivation of both pRB and p53 tumor suppressor pathways that promotes CIN.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23792446      PMCID: PMC3884049          DOI: 10.1038/onc.2013.201

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  62 in total

1.  p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest.

Authors:  S H Khan; G M Wahl
Journal:  Cancer Res       Date:  1998-02-01       Impact factor: 12.701

2.  Distinct roles for E2F proteins in cell growth control and apoptosis.

Authors:  J DeGregori; G Leone; A Miron; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function.

Authors:  A Di Leonardo; S H Khan; S P Linke; V Greco; G Seidita; G M Wahl
Journal:  Cancer Res       Date:  1997-03-15       Impact factor: 12.701

4.  Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

Authors:  T Kuukasjärvi; R Karhu; M Tanner; M Kähkönen; A Schäffer; N Nupponen; S Pennanen; A Kallioniemi; O P Kallioniemi; J Isola
Journal:  Cancer Res       Date:  1997-04-15       Impact factor: 12.701

5.  p53 and E2F-1 cooperate to mediate apoptosis.

Authors:  X Wu; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 6.  Genetic predisposition to cancer.

Authors:  A G Knudson
Journal:  Cancer Detect Prev       Date:  1984

7.  Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts.

Authors:  R E Herrera; V P Sah; B O Williams; T P Mäkelä; R A Weinberg; T Jacks
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

8.  Genetic instability in colorectal cancers.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

9.  Mutations of mitotic checkpoint genes in human cancers.

Authors:  D P Cahill; C Lengauer; J Yu; G J Riggins; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

10.  Chromosomal instability determines taxane response.

Authors:  Charles Swanton; Barbara Nicke; Marion Schuett; Aron C Eklund; Charlotte Ng; Qiyuan Li; Thomas Hardcastle; Alvin Lee; Rajat Roy; Philip East; Maik Kschischo; David Endesfelder; Paul Wylie; Se Nyun Kim; Jie-Guang Chen; Michael Howell; Thomas Ried; Jens K Habermann; Gert Auer; James D Brenton; Zoltan Szallasi; Julian Downward
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-19       Impact factor: 11.205

View more
  19 in total

1.  Suppression of genome instability in pRB-deficient cells by enhancement of chromosome cohesion.

Authors:  Amity L Manning; Stephanie A Yazinski; Brandon Nicolay; Alysia Bryll; Lee Zou; Nicholas J Dyson
Journal:  Mol Cell       Date:  2014-03-06       Impact factor: 17.970

Review 2.  Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.

Authors:  Chinthalapally V Rao; Adam S Asch; Hiroshi Y Yamada
Journal:  Carcinogenesis       Date:  2016-11-12       Impact factor: 4.944

3.  Suppression of Chromosome Instability Limits Acquired Drug Resistance.

Authors:  Elizabeth A Crowley; Nicole M Hermance; Conor P Herlihy; Amity L Manning
Journal:  Mol Cancer Ther       Date:  2022-10-07       Impact factor: 6.009

4.  Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents.

Authors:  Guangan He; Xiaolei Xie; Zahid H Siddik
Journal:  Cancer Chemother Pharmacol       Date:  2020-05-28       Impact factor: 3.333

5.  In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis.

Authors:  S Vaidyanathan; K Cato; L Tang; S Pavey; N K Haass; B G Gabrielli; P H G Duijf
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

6.  Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients.

Authors:  Henry Okuchukwu Ebili; Victoria O Iyawe; Kikelomo Rachel Adeleke; Babatunde Abayomi Salami; Adekunbiola Aina Banjo; Chris Nolan; Emad Rakha; Ian Ellis; Andrew Green; Ayodeji Olayinka Johnson Agboola
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

Review 7.  Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies.

Authors:  Susumu Kohno; Shunsuke Kitajima; Nobunari Sasaki; Chiaki Takahashi
Journal:  World J Stem Cells       Date:  2016-04-26       Impact factor: 5.326

8.  Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.

Authors:  Karolina Weiner-Gorzel; Eugene Dempsey; Malgorzata Milewska; Aloysius McGoldrick; Valerie Toh; Aoibheann Walsh; Sinead Lindsay; Luke Gubbins; Aoife Cannon; Daniel Sharpe; Jacintha O'Sullivan; Madeline Murphy; Stephen F Madden; Malcolm Kell; Amanda McCann; Fiona Furlong
Journal:  Cancer Med       Date:  2015-02-15       Impact factor: 4.452

9.  Conditional haploinsufficiency of the retinoblastoma tumor suppressor gene.

Authors:  Charles A Ishak; Frederick A Dick
Journal:  Mol Cell Oncol       Date:  2014-10-30

10.  Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma.

Authors:  Junyu Huo; Liqun Wu; Yunjin Zang
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.